Literature DB >> 1910285

pH-sensitive control of arginase by Mn(II) ions at submicromolar concentrations.

N J Kuhn1, J Talbot, S Ward.   

Abstract

The manganese dependence of arginase was reinvestigated with extracts of mouse liver to see whether more physiological properties were displayed than have been reported for the purified enzyme. In a preincubation with Mn(II) ions at 37 degrees C the enzyme underwent a slow and reversible activation. At least 90-95% of the activation achieved was dependent on Mn2+. However, no Mn2+ was required for catalytic activity in the assay. The activation showed little dependence upon pH over the range 6.5-9.5, whereas the catalytic activity increased 12-fold in apparent accord with the titration curve of an ionizable group of pKa 7.9. The Mn2+ dependence of arginase activation obeyed Michaelis-Menten kinetics, with Kd varying from 0.3 microM at pH 6.8 to 0.08 microns at pH 7.7. Free Mn2+ concentrations were established in these assays with a trimethylenediaminetetraacetate-Mn buffer. Vmax increased about three-fold over this range. The calculated arginase activity at 0.05 microM Mn2+ increases about nine-fold over this physiological pH range. An enzyme model is proposed to explain these findings. The activity of arginase at "physiological" [Mn2+] and the pronounced pH dependence conferred upon it are consistent with a recently revised role for the urea cycle in the control of bicarbonate and pH in the body. It appears possible that arginase loses Mn2+ sensitivity during the usual purification.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1910285     DOI: 10.1016/0003-9861(91)90031-d

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  7 in total

1.  Structure and mechanism of action of a novel phosphoglycerate mutase from Bacillus stearothermophilus.

Authors:  M J Jedrzejas; M Chander; P Setlow; G Krishnasamy
Journal:  EMBO J       Date:  2000-04-03       Impact factor: 11.598

2.  Reduced bioavailable manganese causes striatal urea cycle pathology in Huntington's disease mouse model.

Authors:  Terry Jo V Bichell; Michal Wegrzynowicz; K Grace Tipps; Emma M Bradley; Michael A Uhouse; Miles Bryan; Kyle Horning; Nicole Fisher; Karrie Dudek; Timothy Halbesma; Preethi Umashanker; Andrew D Stubbs; Hunter K Holt; Gunnar F Kwakye; Andrew M Tidball; Roger J Colbran; Michael Aschner; M Diana Neely; Alba Di Pardo; Vittorio Maglione; Alexander Osmand; Aaron B Bowman
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-02-16       Impact factor: 5.187

3.  Structure and mechanism of a proline-specific aminopeptidase from Escherichia coli.

Authors:  M C Wilce; C S Bond; N E Dixon; H C Freeman; J M Guss; P E Lilley; J A Wilce
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

4.  Replacing Mn(2+) with Co(2+) in human arginase i enhances cytotoxicity toward l-arginine auxotrophic cancer cell lines.

Authors:  Everett M Stone; Evan S Glazer; Lynne Chantranupong; Paul Cherukuri; Robert M Breece; David L Tierney; Steven A Curley; Brent L Iverson; George Georgiou
Journal:  ACS Chem Biol       Date:  2010-03-19       Impact factor: 5.100

Review 5.  Targeted cellular metabolism for cancer chemotherapy with recombinant arginine-degrading enzymes.

Authors:  Macus Tien Kuo; Niramol Savaraj; Lynn G Feun
Journal:  Oncotarget       Date:  2010-08

6.  Purification, properties and alternate substrate specificities of arginase from two different sources: Vigna catjang cotyledon and buffalo liver.

Authors:  Snehal Dabir; Pankaj Dabir; Baburao Somvanshi
Journal:  Int J Biol Sci       Date:  2005-08-01       Impact factor: 6.580

Review 7.  Arginine Metabolism in Bacterial Pathogenesis and Cancer Therapy.

Authors:  Lifeng Xiong; Jade L L Teng; Michael G Botelho; Regina C Lo; Susanna K P Lau; Patrick C Y Woo
Journal:  Int J Mol Sci       Date:  2016-03-11       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.